G蛋白偶联胆汁酸受体
脂肪变性
胆汁酸
化学
兴奋剂
内科学
基因剔除小鼠
内分泌学
法尼甾体X受体
受体
脂质代谢
肠促胰岛素
脱氧胆酸
下调和上调
肝X受体
甘油三酯
免疫系统
信号转导
β氧化
肠内分泌细胞
肝受体同系物-1
胆酸
脂肪酸
脂肪肝
肉豆蔻酸
罗格列酮
非酒精性脂肪肝
作者
Eunyoung Lee,Ryo Hatano,Mariko Takami,Masanori Fujimoto,Hayato Yoshikawa,Yukihiro Endo,Ryo Koyama‐Nasu,Atsushi Onodera,Jing Li,Sergio Rodríguez‐Cuenca,Sonia Rodríguez‐Fdez,Ioannis Kamzolas,Yu-Hung Lin,Guillaume Bidault,Tomoe Noda,Hitoshi Shimano,Motoko Y. Kimura,Shinichiro Motohashi,Tomoaki Tanaka,Antonio Vidal‐Puig
出处
期刊:Cell Reports
[Cell Press]
日期:2026-08-01
卷期号:45 (8): 117822-117822
标识
DOI:10.1016/j.celrep.2026.117822
摘要
Hepatosteatosis is a common metabolic disorder. Bile acids influence hepatosteatosis, immune function, and incretin secretion. However, whether bile acids mediate hepatosteatosis through these immune or endocrine pathways remain unknown. Here, we identify supplementation with hyodeoxycholic acid (HDCA) in high-fat diet-fed mice increases hepatic iNKT cells and elevates circulating GLP-1, both upregulating fatty acid oxidation genes in a PPARα-dependent manner. Mechanistically, HDCA increases iNKT cells and IFN-γ production that promotes hepatic lipid catabolism, thereby attenuating triglyceride accumulation in wild-type (WT) mice, but not in iNKT cell-deficient ( Ja18 −/− ) and PPARα knockout ( Ppara −/− ) mice. By contrast, the GLP-1 receptor agonist suppresses high-fat diet-induced steatosis in WT and Ja18 −/− mice, but not in Ppara −/− and GLP-1 receptor knockout ( Glp1r −/− ) mice. Furthermore, anti-steatotic effect of HDCA is nullified in Glp1r −/− mice. Consequently, HDCA alleviates hepatosteatosis through dual mechanisms; an iNKT cell/IFN-γ immunometabolic- and GLP-1-dependent pathways. These findings highlight HDCA as a promising multi-target therapeutic strategy for hepatosteatosis.
科研通智能强力驱动
Strongly Powered by AbleSci AI